What is the management for post-extubation stridor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Post-Extubation Stridor

Inhaled epinephrine should be used as first-line treatment for post-extubation stridor in conscious patients, followed by systemic corticosteroids if symptoms persist. 1, 2

Assessment and Diagnosis

  • Post-extubation stridor affects 1-30% of extubated patients, typically presenting within minutes following extubation 1

  • Risk factors include:

    • Female sex
    • Prolonged intubation (>48 hours)
    • Traumatic or difficult intubation
    • Large endotracheal tube size
    • High cuff pressures
    • Nasal intubation
    • Non-elective intubation 2, 3
  • The cuff leak test should be performed before extubation in high-risk patients:

    • A leak <110 ml or <10% of tidal volume indicates high risk
    • Good specificity (92%) but moderate sensitivity (56%) 2

Treatment Algorithm

1. First-Line Treatment

  • Nebulized epinephrine (L-epinephrine 1% solution or racemic epinephrine 2.25%)
    • Both formulations are equally effective 4
    • Effects last 30 minutes to 2 hours, requiring continuous monitoring
    • May need repeated doses 1, 2

2. Second-Line Treatment

  • Systemic corticosteroids
    • Dexamethasone IV (>0.3 mg/kg)
    • Continue for at least 48 hours
    • Reduces reintubation rates (5.8% vs 17.0%) 2

3. Adjunctive Measures

  • Heliox (helium-oxygen mixture)
    • Reduces stridor scores and respiratory distress
    • Particularly useful in pediatric patients 5
  • Continuous positive airway pressure (CPAP)
    • Apply with 100% oxygen using reservoir bag and facemask
    • Ensure upper airway patency 1

4. For Refractory Cases

  • Larson's maneuver:

    • Place middle finger of each hand between posterior mandible border and mastoid process
    • Displace mandible forward in jaw thrust
    • Apply deep pressure to relieve laryngospasm 1
  • Reintubation if respiratory failure develops:

    • Consider propofol (1-2 mg/kg IV) for early laryngospasm
    • Suxamethonium (1 mg/kg IV) for severe cases with total cord closure 1

Prevention

  • Prophylactic corticosteroids:

    • Administer to high-risk patients with positive cuff leak test
    • Start at least 6 hours before extubation, preferably 12-24 hours
    • Multiple doses are more effective than single doses 2, 6
  • Preventive measures:

    • Use appropriate tube size (typically 8mm for men, 7mm for women)
    • Minimize intubation duration
    • Monitor and regulate cuff pressure 1

Monitoring and Follow-up

  • Close observation for at least 24 hours after treatment

  • Warning signs requiring immediate attention:

    • Worsening stridor
    • Increased work of breathing
    • Oxygen desaturation
    • Agitation 1
  • Consider otolaryngology consultation for:

    • Persistent stridor despite treatment
    • Need for reintubation
    • Suspicion of structural laryngeal injury 2

Differential Diagnosis

Be aware of other causes of post-extubation stridor:

  • Paradoxical vocal cord movement (more common in young females)
  • Tracheal pseudomembranes (rare but life-threatening) 7
  • Aspiration of blood clots
  • Laryngospasm 1, 2

Special Considerations

  • In pediatric patients, particularly infants:
    • Higher risk of post-extubation stridor
    • ETT size selection is critical (4.0 ETTs associated with higher risk than 3.5 ETTs) 3
    • Multiple doses of corticosteroids may be beneficial in high-risk neonates 6

Remember that post-extubation stridor is a potentially life-threatening condition requiring prompt recognition and treatment. Always have equipment for difficult airway management readily available when managing these patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.